发明公开
- 专利标题: SAK: MODULATION OF CELLULAR PROLIFERATION FOR TREATMENT OF CANCER
- 专利标题(中): SAK:调制癌症治疗的细胞增殖
-
申请号: EP02750377.0申请日: 2002-07-31
-
公开(公告)号: EP1549760A2公开(公告)日: 2005-07-06
- 发明人: DEMO, Susan , HITOSHI, Yasumichi , JENKINS, Yonchu
- 申请人: Rigel Pharmaceuticals, Inc.
- 申请人地址: 240 E. Grand Avenue South San Francisco, CA 94080 US
- 专利权人: Rigel Pharmaceuticals, Inc.
- 当前专利权人: Rigel Pharmaceuticals, Inc.
- 当前专利权人地址: 240 E. Grand Avenue South San Francisco, CA 94080 US
- 代理机构: Manitz, Finsterwald & Partner GbR
- 优先权: US309632P 20010801; US26021 20011221
- 国际公布: WO2003012055 20030213
- 主分类号: C12Q1/68
- IPC分类号: C12Q1/68 ; C12Q1/48 ; G01N33/53 ; A61K39/395 ; A61K48/00 ; A61K7/46
摘要:
The present invention relates to regulation of cellular proliferation. More particularly, the present invention is directed to nucleic acids encoding SAK, which is a protein kinase involved in modulation of cellular proliferation and cell cycle regulation. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions, antibodies, peptides, cyclic peptides, nucleic acids, RNAi, antisense nucleic acids, and ribozymes, that modulate cell cycle regulation and cellular proliferation via modulation of SAK; as well as to the use of expression profiles and compositions in diagnosis and therapy related to cell cycle regulation and modulation of cellular proliferation, e.g., for treatment of cancer and other diseases of cellular proliferation.
公开/授权文献
信息查询